Abreos Biosciences

San Diego, United States Founded: 2013 • Age: 13 yrs
Developing point-of-care tests for personalized dosing and counterfeit detection of biologic drugs
Annual revenue - Latest available
Total funding $725,000 12 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Abreos Biosciences

Abreos Biosciences is a company based in San Diego (United States) founded in 2013. Abreos Biosciences has raised $725 thousand across 12 funding rounds from investors including HHS, SBIR and unknown. Abreos Biosciences operates in a competitive market with competitors including IntegenX, Precision Diagnostics, Ameritox, Psychemedics and InnoGenomics, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Abreos Biosciences, Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $725 K (USD)

    in 12 rounds

  • Latest Funding Round
    $1.88 M (USD), Grant

    Feb 01, 2018

  • Investors
    HHS

    & 2 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Abreos Biosciences

Abreos Biosciences has successfully raised a total of $725K across 12 strategic funding rounds. The most recent funding activity was a Grant round of $1.88 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Abreos Biosciences

Abreos Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, SBIR and unknown.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Locked Locked Locked
Federal innovation and scientific achievement services are provided.
Locked Locked Locked
Premium access

Investor details for Abreos Biosciences

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Abreos Biosciences

Investments
Premium access

Investment portfolio details for Abreos Biosciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Abreos Biosciences

Premium access

Detailed financials for Abreos Biosciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Abreos Biosciences Comparisons

Abreos Biosciences Primary company
Description
Developing point-of-care tests for personalized dosing and c...
Location
San Diego, United States
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Abreos Biosciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Abreos Biosciences

Abreos Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IntegenX, Precision Diagnostics, Ameritox, Psychemedics and InnoGenomics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Instruments for rapid human DNA identification are developed.
Locked Locked Locked
Quantitative urine drug testing is provided for patient monitoring.
Locked Locked Locked
Pain medication monitoring solutions are provided for US clinicians.
Locked Locked Locked
Drug abuse detection services are provided through hair sample testing.
Locked Locked Locked
Develops DNA testing kits
Premium access

Detailed competitors of Abreos Biosciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Abreos Biosciences

Premium access

Complete news archive for Abreos Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abreos Biosciences

Abreos Biosciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Abreos Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Abreos Biosciences is a funded company, having raised a total of $725K across 12 funding rounds to date.

Founded in 2013 in San Diego, United States, Abreos Biosciences operates in the biotechnology sector, focusing on diagnostic assays for biologic drugs. The Veritope platform is utilized to create mimetope peptides that replicate ligands targeted by monoclonal antibodies. These peptides enable quantitative detection in serum, blood, or compounding solutions via ELISA or lateral flow methods. Applications include pharmacokinetics monitoring and counterfeit identification for antibody therapies.

Abreos Biosciences's top competitors include IntegenX, Precision Diagnostics and Psychemedics.

Abreos Biosciences has 3 investors. Key investors include HHS, SBIR, and unknown.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available